The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at $18,720.90 to DMS Pharmaceutical Group Inc. The order is for 1,000 vial units of KCENTRA to be delivered to a location in Park Ridge, Illinois, with performance required between September 29, 2023 and October 23, 2023. KCENTRA is a plasma-derived four-factor prothrombin complex concentrate indicated for the urgent reversal of acquired coagulation factor deficiencies induced by vitamin K antagonist therapies. The delivery order was issued against an unidentified DLA-wide contract vehicle to fulfill the agency's needs to maintain critical blood factor supplies for the U.S. military health system. No subcontractors or set-aside designations were noted.
Generated 12/29/23, 9:05 AM